share_log
Moomoo 24/7 ·  Apr 15 09:32
Neumora Therapeutics Shares Down 17% After US FDA Puts Schizophrenia Drug Trial on Hold
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment